Impact of induction intensity and transplantation on outcomes of patients with complex karyotype and TP53-mutated acute myeloid leukemia

被引：1
|
作者：
Jamy, Omer [1 ]
Diebold, Kendall [1 ]
Davis, Kenneth [2 ]
Bachiashvili, Kimo [1 ]
Rangaraju, Sravanti [1 ]
Vachhani, Pankit [1 ]
Godby, Kelly N. [1 ]
Salzman, Donna [1 ]
Bhatia, Ravi [1 ]
机构：
[1] Univ Alabama Birmingham, Div Hematol & Oncol, Dept Med, Birmingham, AL 35233 USA
[2] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA
来源：
BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / 07期
关键词：
D O I：
10.1038/s41409-023-01977-7
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：823 / 825
页数：3
相关论文
共 50 条
  • [31] TP53 mutated acute myeloid leukemia
    Sill, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 257 - 257
  • [32] Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1α with echinomycin
    Wang, Yin
    Liu, Yan
    Bailey, Christopher
    Zhang, Huixia
    He, Miao
    Sun, Duxin
    Zhang, Peng
    Parkin, Brian
    Baer, Maria R.
    Zheng, Pan
    Malek, Sami N.
    Liu, Yang
    ONCOGENE, 2020, 39 (14) : 3015 - 3027
  • [33] TP53-Mutated Myelodysplastic Syndrome and Acute Myeloid Leukemia: Biology, Current Therapy, and Future Directions
    Daver, Naval G.
    Maiti, Abhishek
    Kadia, Tapan M.
    Vyas, Paresh
    Majeti, Ravindra
    Wei, Andrew H.
    Garcia-Manero, Guillermo
    Craddock, Charles
    Sallman, David A.
    Kantarjian, Hagop M.
    CANCER DISCOVERY, 2022, 12 (11) : 2516 - 2529
  • [34] TP53-mutated acute myeloid leukemia and myelodysplastic syndrome: biology, treatment challenges, and upcoming approaches
    Pereira, Mariana Pinto
    Herrity, Elizabeth
    Kim, Dennis D. H.
    ANNALS OF HEMATOLOGY, 2024, 103 (04) : 1049 - 1067
  • [35] Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1α with echinomycin
    Yin Wang
    Yan Liu
    Christopher Bailey
    Huixia Zhang
    Miao He
    Duxin Sun
    Peng Zhang
    Brian Parkin
    Maria R. Baer
    Pan Zheng
    Sami N. Malek
    Yang Liu
    Oncogene, 2020, 39 : 3015 - 3027
  • [36] The Current Understanding of and Treatment Paradigm for Newly-Diagnosed TP53-Mutated Acute Myeloid Leukemia
    Shallis, Rory M.
    Stahl, Maximilian
    Bewersdorf, Jan Philipp
    Zeidan, Amer M.
    Testa, Ugo
    Walter, Roland B.
    HEMATO, 2021, 2 (04): : 748 - 763
  • [37] Treatment outcomes for newly diagnosed, untreated TP53-mutated acute myeloid leukemia: A systematic review and meta-analysis.
    Daver, Naval Guastad
    Iqbal, Shahed
    Renard, Camille
    Chan, Rebecca J.
    Hasegawa, Ken
    Hu, Hao
    Tse, Preston
    Yan, Jiajun
    Zoratti, Michael J.
    Xie, Feng
    Ramsingh, Giridharan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E19020 - E19020
  • [38] TP53-mutated acute myeloid leukemia and myelodysplastic syndrome: biology, treatment challenges, and upcoming approaches
    Mariana Pinto Pereira
    Elizabeth Herrity
    Dennis D.H Kim
    Annals of Hematology, 2024, 103 : 1049 - 1067
  • [39] TP53-mutated Acute Myeloid Leukemia with Myelodysplasia-Related Changes and TherapyRelated Acute Myeloid Leukemia Have Comparable TP53 Mutational Signature and Clinical Features
    Tashakori, Mehrnoosh
    Tapan, Kadia
    Loghavi, Sanam
    Tang, Zhenya
    Routbort, Mark
    Ravandi-Kashani, Farhad
    Khoury, Joseph
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1027 - 1028
  • [40] Post-Transplant T Cell Clonotype Diversity Is Associated with Survival in Patients with TP53-Mutated Acute Myeloid Leukemia
    Sariipek, Nurefsan
    Safina, Kseniia R.
    Cutler, Corey
    Ho, Vincent T.
    Koreth, John
    Lindsley, Coleman
    Luskin, Marlise R.
    Garcia, Jacqueline S.
    Hearsey, Doreen
    Lu, Wesley S.
    Li, Shuqiang
    Livak, Kenneth J.
    Griffin, Gabriel K.
    Soiffer, Robert J.
    Ritz, Jerome
    Wu, Catherine J.
    Antin, Joseph H.
    Lane, Andrew A.
    Van Galen, Peter
    Gooptu, Mahasweta
    BLOOD, 2023, 142
12345